Human HMMR ELISA Kit (V2LY-0626-LY3658)

Tarullo, S. E., He, Y., Daughters, C., Knutson, T. P., Henzler, C. M., Price, M. A., ... & Nelson, A. C. (2023). Receptor for hyaluronan‐mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients. The Journal of Pathology.

Mei, L. (2022). Hyaluronan mediated motility receptor regulates daughter cell size control pathways during mitosis (Doctoral dissertation, University of British Columbia).

Sun, H., Ma, L., & Chen, J. (2021). Hyaluronan-mediated motility receptor expression functions as a prognostic biomarker in uterine carcinosarcoma based on bioinformatics analysis. Journal of International Medical Research, 49(6), 03000605211021043.

Tang, Y. P., Yin, Y. X., Xie, M. Z., Liang, X. Q., Li, J. L., Li, K. Z., & Hu, B. L. (2021). Systematic analysis of the clinical significance of hyaluronan-mediated motility receptor in colorectal cancer. Frontiers in Molecular Biosciences, 8, 733271.

Lu, T., Zheng, Y., Gong, X., Lv, Q., Chen, J., Tu, Z., ... & Li, J. (2021). High expression of hyaluronan-mediated motility receptor predicts adverse outcomes: a potential therapeutic target for head and neck squamous cell carcinoma. Frontiers in Oncology, 11, 608842.

Kang, H. G., Kim, W. J., Kang, H. G., Chun, K. H., & Kim, S. J. (2020). Galectin-3 interacts with C/EBPβ and upregulates hyaluronan-mediated motility receptor expression in gastric cancer. Molecular Cancer Research, 18(3), 403-413.

He, Z., Mei, L., Connell, M., & Maxwell, C. A. (2020). Hyaluronan mediated motility receptor (HMMR) encodes an evolutionarily conserved homeostasis, mitosis, and meiosis regulator rather than a hyaluronan receptor. Cells, 9(4), 819.

Ye, S., Liu, Y., Fuller, A. M., Katti, R., Ciotti, G. E., Chor, S., ... & Eisinger-Mathason, T. K. (2020). TGFβ and hippo pathways cooperate to enhance sarcomagenesis and metastasis through the hyaluronan-mediated motility receptor (HMMR). Molecular Cancer Research, 18(4), 560-573.

He, F., Zu, D., Lan, C., Niu, J., & Nie, X. (2020). hsa‑microRNA‑411‑5p regulates proliferation, migration and invasion by targeting the hyaluronan mediated motility receptor in ovarian cancer. Experimental and Therapeutic Medicine, 20(3), 1899-1906.

Zhang, H., Ren, L., Ding, Y., Li, F., Chen, X., Ouyang, Y., ... & Zhang, D. (2019). Hyaluronan‐mediated motility receptor confers resistance to chemotherapy via TGFβ/Smad2‐induced epithelial‐mesenchymal transition in gastric cancer. The FASEB Journal, 33(5), 6365-6377.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols